SHPH
NASDAQ · Biotechnology
Shuttle Pharmaceuticals Hold
$4.11
+0.10 (+2.49%)
Open$3.99
Previous Close$4.01
Day High$4.12
Day Low$3.84
52W High$55.90
52W Low$2.58
Volume—
Avg Volume32.8K
Market Cap15.59M
P/E Ratio—
EPS$-27.52
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 3.31M | 2.94M | 3.37M |
| Net Income | 119.2K | 97.1K | 110.6K |
| Profit Margin | 3.6% | 3.3% | 3.3% |
| EBITDA | 181.4K | 163.4K | 177.0K |
| Free Cash Flow | 96.2K | 133.1K | 131.3K |
| Rev Growth | +15.9% | +11.7% | +12.8% |
| Debt/Equity | 0.66 | 0.73 | 0.66 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |